Phase 2 Obesity & Overweight trials recruiting now

All Obesity & Overweight trials, every phase

Other phases for Obesity & Overweight

Phase 2 Obesity & Overweight trials

• A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
  NCT07570758 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 3 locations
• Bariatric Endoscopic Antral Myotomy Combined With Fundal Gastric Mucosal Ablation
  NCT07612527 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
  NCT07336797 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
  NCT07332741 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 8 locations
• Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
  NCT07446998 · Phase: Phase 2 · Ages: 65 Years to 100 Years · Sex: All (male and female) · 14 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.